People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elastrin Therapeutics, Inc. | — | Biotechnology | Series A | $13.3M | $2.4M | 2021 |
| Reservoir Neuroscience, Inc. | — | Biotechnology | Seed | $6.0M | $14.4M | 2023 |
Patrick Burgermeister at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Burgermeister on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tracy Saxton | 1 | 5 |
| Naren Vyavahare | 1 | 2 |
| Brian Slingerland | 1 | 2 |
| Klaus-Dieter Langner | 1 | 1 |
| Matthias Breugelmans | 1 | 1 |
| Vladimir Senatorov | 1 | 1 |
| Aaron Friedman | 1 | 1 |
| James Summers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.